JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB43014

Anti-HIV1 tat antibody - ChIP Grade

4

(4 Reviews)

|

(31 Publications)

Rabbit Polyclonal HIV1 tat antibody. Suitable for EMSA, WB and reacts with Human immunodeficiency virus samples. Cited in 31 publications.

View Alternative Names

Protein Tat, Transactivating regulatory protein, tat

1 Images
Western blot - Anti-HIV1 tat antibody - ChIP Grade (AB43014)
  • WB

AbReview29465****

Western blot - Anti-HIV1 tat antibody - ChIP Grade (AB43014)

Jurkat cells were pNL4.3 infected and samples taken at 2 hour intervals for blotting.

All lanes:

Western blot - Anti-HIV1 tat antibody - ChIP Grade (ab43014) at 1/2000 dilution

Lane 1:

Jurkat whole cell lysate 0 hours after infection at 25 µg

Lane 2:

Jurkat whole cell lysate 2 hours after infection at 25 µg

Lane 3:

Jurkat whole cell lysate 4 hours after infection at 25 µg

Lane 4:

Jurkat whole cell lysate 6 hours after infection at 25 µg

Lane 5:

Jurkat whole cell lysate 8 hours after infection at 25 µg

Lane 6:

Jurkat whole cell lysate 10 hours after infection at 25 µg

Secondary

All lanes:

HRP Goat anti-rabbit IgG polyclonal at 1/10000 dilution

Observed band size: 14 kDa

true

This image is courtesy of an anonymous Abreview

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human immunodeficiency virus

Applications

EMSA, WB

applications

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "EMSA" : {"fullname" : "Electrophoretic Mobility Shift Assay", "shortname":"EMSA"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human immunodeficiency virus": { "EMSA-species-checked": "guaranteed", "EMSA-species-dilution-info": "", "EMSA-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The HIV-1 Tat protein also known as HIV Tat or simply Tat is an important regulatory protein of the Human Immunodeficiency Virus type 1 (HIV-1). It has a mass of approximately 14 to 16 kDa and is important for viral replication. This protein is expressed early in the HIV-1 infection cycle and is localized mainly in the nucleus of infected T-cells. HIV-1 Tat is known for its ability to transactivate the HIV-1 long terminal repeat (LTR) promoter which significantly enhances the production of viral RNA.
Biological function summary

The HIV-1 Tat protein plays an important role in the replication and transcription processes of the HIV-1 virus. It is part of a complex that interacts with other host cellular factors to improve the efficiency of the HIV-1 transcription from the provirus. This interaction is essential for the elongation phase of transcription which results in increased viral gene expression and successful replication of the virus inside host cells.

Pathways

The involvement of the HIV-1 Tat protein extends to interfering with several important biological pathways. It influences the NF-kB pathway which is critical for immune response regulation and interacts with the Cyclin T1 as part of the P-TEFb complex. This interaction is important for the transcriptional activation of the HIV LTR. By affecting the NF-kB pathway Tat protein indirectly modulates inflammatory responses which can lead to altered immune system functions.

HIV-1 Tat protein's primary significance lies in the progression and pathology of HIV/AIDS. Its interactions with host cellular proteins such as CDK9 (a component of P-TEFb) are critical for viral persistence and pathogenesis. Additionally Tat has been implicated in neurological disorders associated with HIV-1 infection often referred to as HIV-associated neurocognitive disorders (HAND). Its influence on the central nervous system arises from its ability to exit infected cells and exert neurotoxic effects in neighboring uninfected neural cells.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Transcriptional activator that increases RNA Pol II processivity, thereby increasing the level of full-length viral transcripts. Recognizes a hairpin structure at the 5'-LTR of the nascent viral mRNAs referred to as the transactivation responsive RNA element (TAR) and recruits the cyclin T1-CDK9 complex (P-TEFb complex) that will in turn hyperphosphorylate the RNA polymerase II to allow efficient elongation. The CDK9 component of P-TEFb and other Tat-activated kinases hyperphosphorylate the C-terminus of RNA Pol II that becomes stabilized and much more processive. Other factors such as HTATSF1/Tat-SF1, SUPT5H/SPT5, and HTATIP2 are also important for Tat's function. Besides its effect on RNA Pol II processivity, Tat induces chromatin remodeling of proviral genes by recruiting the histone acetyltransferases (HATs) CREBBP, EP300 and PCAF to the chromatin. This also contributes to the increase in proviral transcription rate, especially when the provirus integrates in transcriptionally silent region of the host genome. To ensure maximal activation of the LTR, Tat mediates nuclear translocation of NF-kappa-B by interacting with host RELA. Through its interaction with host TBP, Tat may also modulate transcription initiation. Tat can reactivate a latently infected cell by penetrating in it and transactivating its LTR promoter. In the cytoplasm, Tat is thought to act as a translational activator of HIV-1 mRNAs.. Extracellular circulating Tat can be endocytosed by surrounding uninfected cells via the binding to several surface receptors such as CD26, CXCR4, heparan sulfate proteoglycans (HSPG) or LDLR. Neurons are rarely infected, but they internalize Tat via their LDLR. Through its interaction with nuclear HATs, Tat is potentially able to control the acetylation-dependent cellular gene expression. Modulates the expression of many cellular genes involved in cell survival, proliferation or in coding for cytokines or cytokine receptors. Tat plays a role in T-cell and neurons apoptosis. Tat induced neurotoxicity and apoptosis probably contribute to neuroAIDS. Circulating Tat also acts as a chemokine-like and/or growth factor-like molecule that binds to specific receptors on the surface of the cells, affecting many cellular pathways. In the vascular system, Tat binds to ITGAV/ITGB3 and ITGA5/ITGB1 integrins dimers at the surface of endothelial cells and competes with bFGF for heparin-binding sites, leading to an excess of soluble bFGF.
See full target information tat

Publications (31)

Recent publications for all applications. Explore the full list and refine your search

International journal of molecular sciences 26: PubMed40806362

2025

Beyond Protection: The Cytotoxic Effect of Anti-Tat Antibodies in People Living with HIV.

Applications

Unspecified application

Species

Unspecified reactive species

Juan Ernesto Gutiérrez-Sevilla,Jorge Gaona-Bernal,Gracia Viviana González-Enríquez,Martha Escoto-Delgadillo,Guillermo Moisés Zúñiga-González,Belinda Claudia Gómez-Meda,Silvia Gabriela Luévano-Gómez,Alma Minerva Pérez-Ríos,Maribel Ávila-Morán,Víctor Eduardo García-Arias,Jessica Paloma Torres-Ríos,Jhonathan Cárdenas-Bedoya,Blanca Miriam Torres-Mendoza

Marine drugs 23: PubMed40137294

2025

The Polybrominated Diphenyl Ether Bromoxib Disrupts Nuclear Import and Export by Affecting Nucleoporins of the Nuclear Pore Complex.

Applications

Unspecified application

Species

Unspecified reactive species

Karina S Krings,Anastasia Ritchie,Laura Schmitt,Judith Hatzfeld,Gudrun Totzke,Thomas Lenz,María José Mendiburo,Björn Stork,Nicole Teusch,Peter Proksch,Kai Stühler,Lisa Müller,Sebastian Wesselborg

PLoS pathogens 20:e1011821 PubMed38781120

2024

Mitotic deacetylase complex (MiDAC) recognizes the HIV-1 core promoter to control activated viral gene expression.

Applications

Unspecified application

Species

Unspecified reactive species

Emmanuelle Wilhelm,Mikaël Poirier,Morgane Da Rocha,Mikaël Bédard,Patrick P McDonald,Pierre Lavigne,Christie L Hunter,Brendan Bell

Journal of immunology (Baltimore, Md. : 1950) 211:429-442 PubMed37326481

2023

HIV-1 Tat Upregulates TREM1 Expression in Human Microglia.

Applications

Unspecified application

Species

Unspecified reactive species

Grant R Campbell,Pratima Rawat,Rachel K To,Stephen A Spector

Biomolecules 13: PubMed37371461

2023

HIV-1 Transcriptional Activator Tat Inhibits Expression by Preventing the Presence of Pol II on the Promoter.

Applications

Unspecified application

Species

Unspecified reactive species

Spyridoula Anastasopoulou,Tassos Georgakopoulos,Athanasia Mouzaki

Virus research 324:199034 PubMed36581045

2022

Identification of 5' upstream sequence involved in HSPBP1 gene transcription and its downregulation during HIV-1 infection.

Applications

Unspecified application

Species

Unspecified reactive species

Kruthika Iyer,Alapani Mitra,Debashis Mitra

Biochemistry and biophysics reports 27:101101 PubMed34430716

2021

Calpain-1 C2L domain peptide protects mouse hippocampus-derived neuronal HT22 cells against glutamate-induced oxytosis.

Applications

Unspecified application

Species

Unspecified reactive species

Mayu Sugawara,Takumi Abe,Shuya Kasai,Ken Itoh,Taku Ozaki

Frontiers in cell and developmental biology 9:693706 PubMed34277639

2021

HIV-1 Transactivator of Transcription (Tat) Co-operates With AP-1 Factors to Enhance Transcription.

Applications

Unspecified application

Species

Unspecified reactive species

Leonardo Alves de Souza Rios,Lungile Mapekula,Nontlantla Mdletshe,Dharshnee Chetty,Shaheen Mowla

Molecular neurobiology 58:2974-2989 PubMed33586027

2021

Latent HIV-Exosomes Induce Mitochondrial Hyperfusion Due to Loss of Phosphorylated Dynamin-Related Protein 1 in Brain Endothelium.

Applications

Unspecified application

Species

Unspecified reactive species

Partha K Chandra,Ibolya Rutkai,Hogyoung Kim,Stephen E Braun,Asim B Abdel-Mageed,Debasis Mondal,David W Busija

Scientific reports 11:2692 PubMed33514850

2021

Inhibition of HIV-1 gene transcription by KAP1 in myeloid lineage.

Applications

Unspecified application

Species

Unspecified reactive species

Amina Ait-Ammar,Maxime Bellefroid,Fadoua Daouad,Valérie Martinelli,Jeanne Van Assche,Clémentine Wallet,Anthony Rodari,Marco De Rovere,Birthe Fahrenkrog,Christian Schwartz,Carine Van Lint,Virginie Gautier,Olivier Rohr
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com